SR Medical Technology Company Limited
0108.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.95B
Close$
$-0.71
129.6% downside
Current Fair Value
129.6% downsideOvervalued by 129.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.95 Billion |
|---|---|
| Enterprise Value | $11.76 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | -1.32 |
| Outstanding Shares | 3,238,357,411 |
Return
| Return on Equity | -108.23% |
|---|---|
| Return on Assets | -17.56% |
| Return on Invested Capital | -14.76% |
Valuation & Multiples
| P/E Ratio | -42.39 |
|---|---|
| PEG | 1.22 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.64 |
| Enterprise Value to EBIT | -14.23 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 3.97 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SR Medical Technology Company Limited
428 employees
CEO: Chunxian Wei An investment holding company principally engaged in property-related businesses. The company operates through two segments: Property Development and Investment, and Property Management, which provides services for office buildings, residential properties, and car parks.